Back to Treatments

Treatment

ACE Inhibitors / ARBs (e.g., Lisinopril)

1
Conditions
800
Trials
500K
Participants
70%
Average Safety

Condition Evidence

Coronary Artery Disease

800 trials · 500K participants

80% effectiveness · 70% safety
ACE Inhibitors / ARBs (e.g., Lisinopril) | DFDA